Home › Glioma › Ohio › Cleveland
Glioma clinical trials in Cleveland, OH
6 studies for Glioma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
RecruitingPhase 2
- Cleveland Clinic, Cleveland
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
Recruiting
- University Hospitals Cleveland Medical Center, Cleveland
Development of MRF for Characterization of Brain Tumors After Radiotherapy
RecruitingHealthy volunteers welcome
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Cleveland Clinic, Cleveland
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
RecruitingPhase 1
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Glioma trials in other cities
- New York City, NY26 studies
- Houston, TX24 studies
- Boston, MA19 studies
- Washington, DC17 studies
- Philadelphia, PA15 studies
- Columbus, OH15 studies
- San Francisco, CA15 studies
- Miami, FL15 studies
- Durham, NC12 studies
- Chicago, IL12 studies
- Los Angeles, CA11 studies
- Aurora, CO10 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.